Literature DB >> 7020929

Flow cytometry studies of intracellular adriamycin in single cells in vitro.

R E Durand, P L Olive.   

Abstract

Flow cytometry techniques were used to quantify the intracellular fluorescence of Adriamycin in living cells. Additionally, fluorescence-activated cell sorting was utilized to investigate the relationship between intracellular drug concentration and cell viability. Uptake of Adriamycin in cultured cells was found to be highly dependent upon the method of cell growth (e.g., suspension versus monolayer cultures) and on cell density or cell crowding. With constant exposure conditions, however, direct proportionality was observed between mean cellular fluorescence and external Adriamycin concentration. Total cellular fluorescence was found to increase more rapidly than nuclear fluorescence, although both reached an apparent equilibrium in several hr. Under well-controlled exposure conditions, mean cell survival correlated well with mean cellular Adriamycin fluorescence. Similar results were observed for Adriamycin effects on DNA synthesis. Considerable heterogeneity of cellular Adriamycin levels was, however, observed in all cell populations, and fluorescence-activated cell sorting indicated that the cells with the least intracellular Adriamycin did indeed survive best.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020929

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells.

Authors:  A W El-Kareh; T W Secomb
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

2.  A mathematical model for cisplatin cellular pharmacodynamics.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

3.  Adenovirus-delivered PDCD5 counteracts adriamycin resistance of osteosarcoma cells through enhancing apoptosis and inhibiting Pgp.

Authors:  Hui Zhao; Changliang Peng; Guorui Ruan; Junlin Zhou; Yihan Li; Yong Hai
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.

Authors:  Chelsea D Landon; Ji-Young Park; David Needham; Mark W Dewhirst
Journal:  Open Nanomed J       Date:  2011-01-01

5.  Liposome-Mediated Chemotherapeutic Delivery Is Synergistically Enhanced by Ternary Lipid Compositions and Cationic Lipids.

Authors:  Andrea N Trementozzi; Zachary I Imam; Morgan Mendicino; Carl C Hayden; Jeanne C Stachowiak
Journal:  Langmuir       Date:  2019-09-13       Impact factor: 3.882

6.  Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.

Authors:  J C Senturk; S Bohlman; J J Manfredi
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

Review 7.  Drug and radiation resistance in spheroids: cell contact and kinetics.

Authors:  P L Olive; R E Durand
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

8.  Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?

Authors:  R E Durand
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 9.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

10.  Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat.

Authors:  Y Sakaguchi; Y Maehara; S Inutsuka; I Takahashi; M Yoshida; Y Emi; H Baba; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.